Results 211 to 220 of about 1,513,868 (278)

Exploring the gap between sensor‐detected (SDH) and person‐reported hypoglycaemia (PRH): The voice of people living with diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Background and Aims In people with insulin‐treated diabetes experiencing hypoglycaemia, the multicentre Hypo‐METRICS study found that 60% of sensor‐detected hypoglycaemic episodes (SDH) were asymptomatic, and over 40% of person‐reported hypoglycaemia (PRH) occurred at glucose levels ≥70 mg/dL (3.9 mmol/L).
Monika Cigler   +21 more
wiley   +1 more source

Efficacy and safety of once‐weekly insulins in type 2 diabetes: A systematic review and meta‐analysis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Once‐weekly (OW) insulins represent a promising strategy to reduce injection burden and improve adherence in type 2 diabetes management. This meta‐analysis aimed to quantify pooled effect sizes for key biological and clinical outcomes, integrating new findings from the five large trials published in 2025.
Olivier Bourron, Damien Denimal
wiley   +1 more source

Chemical characterization, antimicrobial, and antioxidant potentials of Juniperus phoenicea wood tar. [PDF]

open access: yesPLoS One
Tina S   +9 more
europepmc   +1 more source

Rethinking control‐IQ+ technology: Simple strategies for easy optimization

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Control‐IQ+ is an automated insulin delivery (AID) algorithm approved for people with type 1 diabetes aged 2+ years and adults aged 18+ years with type 2 diabetes. While numerous publications support improved glycaemia and quality of life for people with diabetes, this practice paper is intended to encourage uptake for healthcare professionals
Viral N. Shah   +5 more
wiley   +1 more source

Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study. [PDF]

open access: yesBMJ Open
Ritz PJ   +24 more
europepmc   +1 more source

A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims A retrospective observational cohort study evaluating real‐world outcomes in adults with type 1 diabetes and gastroparesis using automated hybrid closed loop insulin delivery systems (HCL). Materials and Methods All adults with type 1 diabetes and gastroparesis attending King's College Hospital diabetes service and using continuous ...
Rachael J. L. Tan   +11 more
wiley   +1 more source

Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the efficacy and safety of an automated insulin‐glucagon delivery system (AIGD) compared with an automated insulin delivery system (AID). Materials and methods In a 33‐h, randomised, crossover, inpatient study, 13 participants with type 1 diabetes used the DiaCon system in AIGD and AID modes.
Ajenthen G. Ranjan PhD   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy